lethal, concerning, and uniquely treatable: primary aldosteronism, with dr. sadur - august 23, 2023
Published 1 year ago • 358 plays • Length 49:00Download video MP4
Download video MP3
Similar videos
-
14:55
avectas limited
-
5:48
ankyrons: the future of target-binding reagents beyond antibodies
-
1:27
misquito testimonial: a spinefrontier les technology
-
18:15
jeremy fry: ankyrons: the future of target-binding reagents beyond antibodies
-
32:01
proimmune ankyron webinar 29jan2024
-
2:49
integrin-targeted peptide/peptidomimetic-drug conjugates: in-depth analysis of the linker technology
-
6:53
connectome of the week (cotw) episode 05: resecting recurrent glioblastoma
-
0:34
structural mechanisms of mutant huntingtin aggregation suppression by synthetic chaperonin-like...
-
2:50
the awakening
-
1:01:35
new frontiers in immuno-oncology for solid tumor treatment
-
1:00
conductive metallophthalocyanine framework
-
9:06
creative biolabs - camouse™-fully human antibody generation platform
-
2:04
voluntary lobotomy
-
1:50
lessons to be learned from the laquinimod trial for ms
-
13:51
enzyvant therapeutics
-
5:13
megahurts
-
4:42
metaphysical agents (antigen)